Abstract
There has been increased interest in optimizing treatment protocols for antimicrobial agents, with substantial reliance on susceptibility testing of bacterial pathogens isolated from diseased cattle. Antimicrobial susceptibility testing of bovine bacterial pathogens has traditionally used the agar diffusion (Kirby-Bauer) method, which was designed to reflect the antibiotic concentration in serum and interstitial fluid of human patients. The validity of agar diffusion susceptibility breakpoints derived from humans to the treatment of mastitis, diarrhea and respiratory disease in cattle has not been established. The use of susceptibility testing to guide treatment decisions for individual cattle is not recommended until the breakpoints have been validated as being predictive of treatment outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: American Association of Bovine Practitioners Conference Proceedings
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.